{"id":1107,"date":"2025-08-23T06:00:42","date_gmt":"2025-08-23T06:00:42","guid":{"rendered":"https:\/\/perfusfind.com\/ic\/?p=1107"},"modified":"2026-01-27T16:57:33","modified_gmt":"2026-01-27T16:57:33","slug":"biomarkers-to-guide-sepsis-management","status":"publish","type":"post","link":"https:\/\/perfusfind.com\/ic\/index.php\/2025\/08\/23\/biomarkers-to-guide-sepsis-management\/","title":{"rendered":"Biomarkers to guide sepsis management"},"content":{"rendered":"
\n

\ud83e\uddec Biomarkers to Guide Sepsis Management: The Next Frontier<\/p>\n<\/blockquote>\n

Abstract:<\/strong> Sepsis remains a leading global cause of mortality and morbidity. This review highlights how biomarkers<\/strong>\u2014from inflammatory mediators to endothelial and immune markers\u2014are increasingly being used to guide key elements of sepsis management: early diagnosis, antibiotic stewardship, fluid therapy, vasopressor initiation, and immunotherapy<\/strong>. Precision therapeutics anchored in biomarker-guided strategies aim to personalize care, improve outcomes, and reduce unnecessary interventions.<\/p>\n

\n
\n
\n
\n
Minimize image<\/div>\n
Edit image<\/div>\n
Delete image<\/div>\n<\/div>\n<\/div>\n

\"\"<\/p>\n<\/div>